LIVE SESSION BRIEF Equities Quant: HOLD

Prenetics Global Limited Warrant (PRENW) โ€” Live Session & Technical Brief

Updated Nov 22, 2026 7:10 AM ET ยท Prev Close $0.01

Pro Workspace
Last Session Price
$0.01 -0.19%
+$0.00 vs $0.01 prior close
Intraday Range
$0.00 โ€“ $0.01
Open $0.01
Relative Volume
23.47x Avg
227,690 sh
52-Week Range
$0.00 โ€“ $0.01
Active range
Benchmark Alpha
+3.45% vs SPY
+5.48% vs QQQ
20-Session Trend -50.9%

Session Regime & Catalyst Assessment

64% Signal Conviction
TECHNICAL 64% Driver Weight

Controlled Session Consolidation (-0.19%) in Equities

Prenetics Global Limited Warrant (PRENW) is trading within a tight intraday band at $0.01 (-0.19%, 23.47x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, PRENW is outperforming the S&P 500 by +3.45%. 14-day RSI stands at 52.3, keeping momentum in a bullish regime.

NEWS 70% Weight
Prenetics Global Limited Q3 2026 Earnings Call Summary

Moby summary of Prenetics Global Limited's Q3 2026 earnings call

TECHNICAL 68% Weight
Moving Average Structure: Bullish Alignment

Price ($0.01) trades relative to 20-day SMA ($0.03) and 50-day SMA ($0.03).

Volume Confirmation
HIGH VOLUME (23.47x) Distribution
Institutional participation confirms directional price action.
Composite Catalyst Confidence 64%
Cross-checked across volume tape, benchmark alpha, options flow, and news.

Market & Sector Relative Strength

PRENW outperforming the S&P 500 by +3.45%
PRENW Session
-0.19%
$0.01
S&P 500 (SPY)
-3.64%
$689.81
Nasdaq 100 (QQQ)
-5.67%
$608.45
Alpha vs SPY: +3.45% Alpha vs QQQ: +5.48%

Recent PRENW Catalyst Headlines

Verified Wire
What Prenetics Global PRE Said on Its Q3 Earnings Call

Prenetics Global Nasdaq Pre reported third-quarter revenue of 64.1 million as sales of its IM8 supplement brand climbed, but widened its expected second-half adjusted EBITDA loss as it plans to spend more on customer acq

Yahoo Finance ยท Nov 18, 2026
Prenetics IM8 Reports Q3 2026 Revenue Growth of 266 YoY Earliest Customers Have Returned More Than 3x Their Acquisition Cost in Under Two Years Reaffirms FY 2026 Total Revenue Guidance of 220 230 Million and FY 2027 IM8 Revenue Guidance of 400 Million

Total revenue of 64.1 million, up 228 YoY 3.3x above the Company s guidance of 63 64 million IM8 revenue of 62.9 million, up 266 YoY 3.7x above the Company s guidance of 61.5 62.5 million, marking the seventh consecutive

Yahoo Finance ยท Nov 18, 2026

1โ€“3 Day Expected Range & Key Level

54% Follow-Through
Lower Bound
$0.01
Short-term support band
Upper Bound
$0.01
Short-term resistance band

Technical Regime (PRENW)

BULLISH MA TREND
RSI (14)
52.3
Bullish
20-Day SMA
$0.03
Below 20d
50-Day SMA
$0.03
Below 50d
MACD Signal
Bearish
MACD 0.00
ADX (14)
21.8
Moderate trend
10d Momentum
+0.00
Soft 10-day momentum

About Prenetics Global Limited Warrant

Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury โ€ฆ

Sector
Equities
Employees
285

Get Instant PRENW Catalyst Alerts

Receive an email alert when PRENW triggers an unusual volume breakout, options sweep, or rating shift.

PRENW Session & Catalyst FAQ

Why is PRENW stock trading near flat today?

Prenetics Global Limited Warrant (PRENW) is trading within a tight intraday band at $0.01 (-0.19%, 23.47x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, PRENW is outperforming the S&P 500 by +3.45%. 14-day RSI stands at 52.3, keeping momentum in a bullish regime.

Is PRENW stock a buy or sell right now?

Today's session carries a 64% catalyst conviction score on 23.47x relative volume (high participation). Our multi-factor model currently rates PRENW as HOLD. Review full valuation, quality, and timing signals on the PRENW Buy or Sell Decision Brief โ†’

What is PRENW's intrinsic value and expected trading range?

At $0.01, PRENW's modeled 1-to-3 session range is $0.01 โ€“ $0.01. Compare current price against multi-year cash flow projections in the PRENW Intrinsic Value & DCF Model โ†’ and Market Cycle Phase Tracker โ†’

What do RSI and moving averages signal for PRENW?

RSI at 52.3 reflects constructive bullish momentum. PRENW trades at $0.01 relative to its 20-day SMA ($0.03) and 50-day SMA ($0.03), reflecting a bullish moving-average structure.

Tradestie Flagship Research & Market Hubs